PL2968139T3 - Platforma miejscowego podania mikroemulsji - Google Patents

Platforma miejscowego podania mikroemulsji

Info

Publication number
PL2968139T3
PL2968139T3 PL14720786T PL14720786T PL2968139T3 PL 2968139 T3 PL2968139 T3 PL 2968139T3 PL 14720786 T PL14720786 T PL 14720786T PL 14720786 T PL14720786 T PL 14720786T PL 2968139 T3 PL2968139 T3 PL 2968139T3
Authority
PL
Poland
Prior art keywords
application platform
microemulsion
topical
topical microemulsion
platform
Prior art date
Application number
PL14720786T
Other languages
English (en)
Polish (pl)
Inventor
Ronald A. Wassel
Fadee George Mondalek
Rafal A. Farjo
Alexander B. QUIAMBAO
Didier J NUNO
Original Assignee
EyeCRO, LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EyeCRO, LLC filed Critical EyeCRO, LLC
Publication of PL2968139T3 publication Critical patent/PL2968139T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14720786T 2013-03-14 2014-03-13 Platforma miejscowego podania mikroemulsji PL2968139T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784005P 2013-03-14 2013-03-14
EP14720786.4A EP2968139B1 (en) 2013-03-14 2014-03-13 Microemulsion topical delivery platform
PCT/US2014/025773 WO2014160079A1 (en) 2013-03-14 2014-03-13 Microemulsion topical delivery platform

Publications (1)

Publication Number Publication Date
PL2968139T3 true PL2968139T3 (pl) 2018-10-31

Family

ID=50628949

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14720786T PL2968139T3 (pl) 2013-03-14 2014-03-13 Platforma miejscowego podania mikroemulsji

Country Status (12)

Country Link
US (2) US8968775B2 (enExample)
EP (1) EP2968139B1 (enExample)
JP (1) JP6348567B2 (enExample)
CN (1) CN105451718B (enExample)
AU (1) AU2014244154B2 (enExample)
CA (1) CA2905023C (enExample)
DK (1) DK2968139T3 (enExample)
ES (1) ES2673009T3 (enExample)
PL (1) PL2968139T3 (enExample)
PT (1) PT2968139T (enExample)
TR (1) TR201808197T4 (enExample)
WO (1) WO2014160079A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2041156T3 (en) 2006-07-13 2014-02-24 Achillion Pharmaceuticals Inc 4-AMINO-4-OXOBUTANOYL Peptides AS INHIBITORS OF VIRUS REPLICATION
ES2584534B1 (es) * 2015-03-27 2017-03-13 Retinset, S.L. Formulación tópica oftálmica de bosentan
CA3011538A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamantane derivatives for the treatment of filovirus infection
RS58292B1 (sr) * 2016-07-07 2019-03-29 Salvat Lab Sa Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS
CA3072768C (en) * 2017-08-27 2024-06-11 Rhodes Technologies Pharmaceutical compositions for the treatment of ophthalmic conditions
WO2019099595A1 (en) * 2017-11-14 2019-05-23 The Schepens Eye Research Institute, Inc. NANO-EMULSION OF CBFβ-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVERY
WO2020250252A1 (en) 2019-06-11 2020-12-17 Sifi S.P.A. Microemulsion compositions
KR102676428B1 (ko) * 2019-07-08 2024-06-19 가부시키가이샤 모레스코 마이크로에멀션을 조제하기 위한 조성물, 마이크로에멀션, 이들의 제조 방법, 및 마이크로에멀션의 이용
EP4248962A4 (en) * 2020-11-19 2024-12-04 Nihon University EYE DROPS FOR REDUCING OR PREVENTING RETINAL CIRCULATORY DISRUPTION AND ASSOCIATED DISORDERS OF THE RETINAL NERVE BLOOD VESSELS
EP4408399B1 (en) * 2021-10-01 2025-05-14 University of South Africa A nano emulsified phyto-drug for transdermal treatment of diabetes
AU2024322403A1 (en) * 2023-08-04 2026-02-12 Ads Therapeutics Llc Compositions and methods for delivery of ophthalmological actives
WO2025090133A1 (en) 2023-10-23 2025-05-01 Inmed Pharmaceuticals Inc. Compositions and methods for use of cannabinol compounds in neuroprotection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI398261B (zh) * 2003-12-17 2013-06-11 Alcon Inc 血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
US7569612B1 (en) * 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
WO2009042677A2 (en) * 2007-09-24 2009-04-02 Farjo Rafal A Stat3 inhibiting compositions and methods
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
EP2673049A4 (en) * 2011-02-11 2015-04-08 Psivida Inc METHOD FOR THE TREATMENT OF MOLECULAR SOILS WITH ANTIOTE THERAPEUTICS
WO2013049621A1 (en) * 2011-09-29 2013-04-04 The Board Of Regents Of The University Of Oklahoma Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof

Also Published As

Publication number Publication date
CA2905023A1 (en) 2014-10-02
DK2968139T3 (en) 2018-06-25
PT2968139T (pt) 2018-06-18
JP2016512562A (ja) 2016-04-28
AU2014244154B2 (en) 2018-08-09
EP2968139B1 (en) 2018-05-23
CN105451718A (zh) 2016-03-30
ES2673009T3 (es) 2018-06-19
US20140275263A1 (en) 2014-09-18
AU2014244154A1 (en) 2015-09-24
EP2968139A1 (en) 2016-01-20
CA2905023C (en) 2019-10-15
US20150164846A1 (en) 2015-06-18
US9149453B2 (en) 2015-10-06
CN105451718B (zh) 2018-09-28
US8968775B2 (en) 2015-03-03
WO2014160079A1 (en) 2014-10-02
JP6348567B2 (ja) 2018-06-27
TR201808197T4 (tr) 2018-07-23

Similar Documents

Publication Publication Date Title
FIC20230030I1 (fi) mirikitsumabi
FIC20210025I1 (fi) Lumasiraani
EP2989885A4 (en) HARVESTER
PL2968139T3 (pl) Platforma miejscowego podania mikroemulsji
LT3038654T (lt) Naujas panaudojimas
PT3055308T (pt) Resumo
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK3044389T3 (da) Vinduespost-tværstykke-konstruktion
BR112015032639A2 (pt) Guindaste
DK2973500T3 (da) Bevægelsesplatformkonfiguration
PT3022200T (pt) Novos agentes antimaláricos
ES1078715Y (es) Mosquitera
BR302013006223S1 (pt) Configuração aplicada em gabarito
FI20130007L (fi) Työteline
BR302013002964S1 (pt) Configuração aplicada em sandalia
BR302013002004S1 (pt) Configuração aplicada em bombona
UA28561S (uk) Розгортка опакування
UA28564S (uk) Розгортка опакування
UA28557S (uk) Розгортка опакування
UA28558S (uk) Розгортка опакування
UA28559S (uk) Розгортка опакування
UA28560S (uk) Розгортка опакування
UA28554S (uk) Розгортка опакування
UA28562S (uk) Розгортка опакування
UA28563S (uk) Розгортка опакування